On August 7, 2023, HENRY SCHEIN ($NASDAQ:HSIC) announced total revenue of USD 3100.0 million for the second quarter of FY2023, a 2.3% increase compared to the same period last year. Net income as of June 30, 2023 was USD 140.0 million, representing a decrease of 12.5% year-on-year.
GoodWhale has conducted an analysis of HENRY SCHEIN‘s fundamentals and Risk Rating. The results are in, and HENRY SCHEIN is a medium risk investment in terms of financial and business aspects. GoodWhale has detected two risk warnings in the income sheet and balance sheet. To get the full picture, register on goodwhale.com and take a deeper dive into the analysis. There, you can see the specifics of the risk factors and make an informed decision on whether it is the right investment for you. More…
Risk Rating Analysis
Star Chart Analysis
About the Company
Ownership (Institutional/ Fund Holdings)
Below shows the total revenue, net income and net margin for Henry Schein. More…
Income Statement Reports (Yearly/ Quarterly/ LTM)
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for Henry Schein. More…
Cash Flow Statement (Yearly/ Quarterly/ LTM)
Cash Flow Supplement
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for Henry Schein. More…
Balance Sheet (Yearly/ Quarterly)
Balance Sheet Supplement
||Book Value Per Share
Key Ratios Snapshot
Some of the financial key ratios for Henry Schein are shown below. More…
Income Statement Ratios
Balance Sheet Ratios
Cash Flow Ratios
Other Supplementary Items
|3Y Rev Growth
||3Y Operating Profit Growth
Henry Schein Inc is one of the largest companies in the dental supplies industry.
However, it faces stiff competition from Healthlead PCL, Patterson Companies Inc, and Alfresa Holdings Corp. All four companies are large, international players in the dental supplies industry.
– Healthlead PCL ($SET:HL)
LeadPCL is a Thailand-based company engaged in the manufacture and sale of lead products. The Company offers lead ingots, lead sheets, lead pipes, lead wires, lead oxides and other lead products. It also provides lead recycling services. The Company’s products are used in a range of applications, including in the automotive, electronics, construction and medical industries.
– Patterson Companies Inc ($NASDAQ:PDCO)
Patterson Companies Inc is a leading provider of animal health and dental products and services. The company has a market cap of 2.61B as of 2022 and a return on equity of 16.53%. Patterson Companies Inc operates in the United States, Canada, and Europe. The company’s products and services include veterinary supplies, dental supplies, and diagnostic imaging. Patterson Companies Inc is headquartered in Minneapolis, Minnesota.
– Alfresa Holdings Corp ($TSE:2784)
Alfresa Holdings Corp is a Japanese pharmaceutical and medical equipment company with a market cap of 280.99B as of 2022. The company has a Return on Equity of 6.23%. Alfresa Holdings Corp is engaged in the research, development, manufacture, and sale of pharmaceuticals and medical equipment. The company’s products include drugs for the treatment of cancer, infectious diseases, and cardiovascular diseases; and medical devices for use in surgery, diagnosis, and treatment.
Henry Schein reported total revenue of USD 3100.0 million for the second quarter of FY2023, representing a 2.3% year-on-year increase. However, net income for June 30 2023 decreased 12.5% year-on-year to USD 140.0 million. This indicates that Henry Schein has seen a mixed performance in terms of growth and profitability. Investors should continue to monitor the company closely in order to better understand its financial health and potential for future gains.